scholarly journals Bipolar II compared with bipolar I disorder: baseline characteristics and treatment response to quetiapine in a pooled analysis of five placebo-controlled clinical trials of acute bipolar depression

2016 ◽  
Vol 15 (1) ◽  
Author(s):  
Catherine Datto ◽  
William J. Pottorf ◽  
Louisa Feeley ◽  
Scott LaPorte ◽  
Charlie Liss
Keyword(s):  
Clinical Trials ◽  
Treatment Response ◽  
Bipolar Depression ◽  
Pooled Analysis ◽  
Controlled Clinical Trials ◽  
Bipolar I Disorder ◽  
Bipolar Ii ◽  
Baseline Characteristics

(286) Efficacy of duloxetine in patients with fibromyalgia: Pooled analysis of four placebo-controlled clinical trials

2008 ◽  
Vol 9 (4) ◽  
pp. 47 ◽  
Author(s):  
L. Arnold ◽  
D. Clauw ◽  
M. Wohlreich ◽  
F. Wang ◽  
J. Ahl ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Pooled Analysis ◽  
Controlled Clinical Trials

Effects of Pregabalin in Patients with Neuropathic Pain Previously Treated with Gabapentin: A Pooled Analysis of Parallel-Group, Randomized, Placebo-controlled Clinical Trials

Pain Practice ◽  
2016 ◽  
Vol 17 (6) ◽  
pp. 718-728 ◽  
Author(s):  
John D. Markman ◽  
Troels Staehelin Jensen ◽  
David Semel ◽  
Chunming Li ◽  
Bruce Parsons ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Neuropathic Pain ◽  
Pooled Analysis ◽  
Controlled Clinical Trials ◽  
Parallel Group ◽  
Previously Treated

scholarly journals Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder

2020 ◽  
Vol 2020 ◽  
pp. 1-2
Author(s):  
Joseph Kuo ◽  
Shih-Ku Lin
Keyword(s):  
Clinical Trials ◽  
Depressive Symptoms ◽  
Successful Treatment ◽  
Placebo Effect ◽  
Extended Release ◽  
Bipolar Depression ◽  
Dropout Rate ◽  
Bipolar I Disorder ◽  
High Dropout Rate ◽  
High Doses

Extended-release injectable (ERI) aripiprazole is indicated for schizophrenia and maintenance monotherapy of bipolar I disorder. Clinical trials of aripiprazole failed to exhibit efficacy in the treatment of bipolar depression. It has been suggested that relatively high doses, rapid titration of dose, a high dropout rate, and a high placebo effect might be the reasons of its ineffectiveness. Here, we report a case of a 39-year-old woman with bipolar depression who was successfully treated with ERI aripiprazole.

Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials

2008 ◽  
Vol 10 (2) ◽  
pp. 323-333 ◽  
Author(s):  
Joseph R Calabrese ◽  
Russell F Huffman ◽  
Robin L White ◽  
Suzanne Edwards ◽  
Thomas R Thompson ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Acute Treatment ◽  
Bipolar Depression ◽  
Controlled Clinical Trials ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document